🔗 Share this article

Acclaimed R&B singer D’Angelo died on October 14 at 51 years old after a private battle with pancreatic malignancy.

“The shining star of our family has dimmed his light for us in this life,” his relatives stated. “After a prolonged and brave struggle with the disease, we are deeply saddened to declare that D’Angelo, known to his fans around the globe as D’Angelo, has been called home.”

D’Angelo made a lasting impact on the music industry with his pioneering modern soul style and partnerships with renowned musicians.

He launched his first record, “Brown Sugar,” in 1995 to instant praise. The album achieved No. 4 on Billboard’s Top R&B Albums chart, earned platinum status soon after, and earned multiple award nominations.

However, it was his sophomore release, “Voodoo,” in 2000 that propelled his artistic journey into the stratosphere. The record debuted at the top spot on both the R&B charts and the main album chart. He won two Grammy Awards: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s standing as a icon, albeit a reluctant one, in the public consciousness. The intimate portrayal showed the artist, notably stripped down to his waist, performing directly into the lens.

D’Angelo retreated from the public eye after releasing Voodoo and openly battled with drugs and alcohol. In 2005, he was involved in a serious car crash that left him in grave health.

More than a decade later, his third and final album, “Black Messiah” (2014), confirmed his enduring appeal with a further top chart entry on the soul music rankings and a Grammy for Best R&B Album.

Once more, in his own mysterious way, D’Angelo had limited public outings in the following years.

The singer was announced as a headliner for the 2025 music event, but his performance was called off, due to an “unexpected health issue.”

Even though information is limited about D’Angelo’s health in the months before his death, he had apparently been hospitalized for months and in palliative care for a fortnight.

D’Angelo’s demise is a clear example of the devastating effects of pancreatic cancer, one of the most deadly and hardest to prevent types of the disease, on a brilliant talent whose life was cut short.

“We are saddened that he can only leave dear memories with his family, but we are forever thankful for the heritage of deeply emotional music he leaves behind,” his family said.

Pancreatic Cancer: Lethal and Difficult to Avoid

Pancreatic malignancy affects the digestive organ, a tiny gland that generates the hormone insulin and is vital in breaking down food, among other functions. The position and dimensions of the organ in the body make it more difficult to detect malignancy.

Even though pancreatic cancer accounts for only about 3% of malignancy cases annually in the U.S., it is responsible for seven percent of malignancy fatalities.

Nearly 70,000 people will be found to have pancreatic cancer and roughly 52,000 will die of the illness in 2025.

“This malignancy is one of the most lethal diseases, with an fast-growing mass and poor prognosis. We have limited and ineffective treatment options, and a narrow opportunity to make a significant difference on the lives of patients,” said a cancer specialist.

Since this disease seldom produces initial signs, it’s frequently identified only once the disease is advanced. Although a patient has indicators they are often nonspecific and may be confused with a several everyday ailments.

“As of yet, there is no effective method to detect pancreatic cancer in the initial phases, apart from listening to your body and speaking with your doctor if there are unfamiliar signs,” said a health expert.

Frequent indicators of this disease encompass:

• discomfort in the stomach or back
• weight loss
• yellowing of skin and eyes
• reduced hunger
• brownish urine
• light-colored or greasy stools
• diarrhea
• excessive hunger or thirst
• feeling sick

At 51 years old, D’Angelo’s demise is an exception, as pancreatic cancer is most common in individuals in the sixty-five to seventy-five range. However, many cancers, such as pancreatic cancer, have become increasingly prevalent among younger people.

“This disease diagnosed prior to fifty is considered rare, yet concerningly, doctors are noticing a growing number of younger patients affected by this disease,” said a specialist.

Family History Affects Cancer Risk

Without effective screening tools for pancreatic cancer, experts emphasized the significance of knowing your relatives’ cancer history. Some contributing elements, such as smoking and excess weight also play a role in the onset of pancreatic cancer.

African Americans have the highest incidence of this malignancy in the U.S. and are most likely to be diagnosed with untreatable disease.

“The first step toward lowering one’s risk of this condition is understanding personal risk factors. People should review their genetic background, hereditary factors, and medical conditions, such as blood sugar disease, long-term pancreas inflammation, or obesity that may increase their vulnerability,” advised a specialist.

Inherited genetic risk factors are linked to as much as ten percent of all pancreatic cancer cases. If a relative in your family has had this disease, you may want to consider DNA analysis.

“For people with a relative’s background of pancreatic cancer or those carrying elevated risk genetic mutations, checking may involve advanced imaging such as magnetic resonance imaging (MRI) or internal ultrasound to detect early changes in the organ,” he explained.

For those wishing to lower their chance, habit adjustments may make a difference. The best action you can take to reduce your susceptibility of pancreatic cancer is to quit smoking, and if you don’t smoke, stay away altogether.

Heavy drinking is linked to pancreatitis, a risk factor for this malignancy, so reducing or avoiding alcohol may help lower your chance.

Controlling your weight or shedding pounds may also help decrease your susceptibility. Individuals with excess weight are twenty percent more prone to develop this disease. Pancreatic cancer also is more frequent in people with blood sugar issues, and reducing weight can also lower the chance of type 2 diabetes.

In spite of this disease’s poor prognosis, there is reason for optimism.

“We are making progress with treatments and newer combination chemotherapy. There are emerging precision medicines that already are showing results,” remarked a specialist.

For many people, however, education about this rare but {dev